Macias Devin A, Adhikari Emily H, Eddins Michelle, Nelson David B, McIntire Don D, Duryea Elaine L
Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical Center, Dallas, TX.
Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical Center, Dallas, TX.
Am J Obstet Gynecol. 2022 Mar;226(3):407.e1-407.e7. doi: 10.1016/j.ajog.2021.09.003. Epub 2021 Sep 14.
There are approximately 1.2 million cesarean deliveries performed each year in the United States alone. While traditional postoperative pain management strategies previously relied heavily on opioids, practitioners are now moving toward opioid-sparing protocols using multiple classes of nonnarcotic analgesics. Multimodal pain management systems have been adopted by other surgical specialties including gynecology, although the data regarding their use for postoperative cesarean delivery pain management remain limited.
To determine if a multimodal pain management regimen after cesarean delivery reduces the required number of morphine milligram equivalents (a unit of measurement for opioids) compared with traditional morphine patient-controlled analgesia while adequately controlling postoperative pain.
This was a prospective cohort study of postoperative pain management for women undergoing cesarean delivery at a large county hospital. It was conducted during a transition from a traditional morphine patient-controlled analgesia regimen to a multimodal regimen that included scheduled nonsteroidal anti-inflammatory drugs and acetaminophen, with opioids used as needed. The data were collected for a 6-week period before and after the transition. The primary outcome was postoperative opioid use defined as morphine milligram equivalents in the first 48 hours. The secondary outcomes included serial pain scores, time to discharge, and exclusive breastfeeding rates. Women who required general anesthesia or had a history of substance abuse disorder were excluded. The statistical analyses included the Student t test, Wilcoxon rank-sum, and Hodges-Lehman shift, with a P value <.05 being considered significant.
During the study period, 877 women underwent cesarean delivery and 778 met the inclusion criteria-378 received the traditional morphine patient-controlled analgesia and 400 received the multimodal regimen. The implementation of a multimodal regimen resulted in a significant reduction in the morphine milligram equivalent use in the first 48 hours (28 [14-41] morphine milligram equivalents vs 128 [86-174] morphine milligram equivalents; P<.001). Compared with the traditional group, more women in the multimodal group reported a pain score ≤4 by 48 hours (88% vs 77%; P<.001). There was no difference in the time to discharge (P=.32). Of the women who exclusively planned to breastfeed, fewer used formula before discharge in the multimodal group than in the traditional group (9% vs 12%; P<.001).
Transition to a multimodal pain management regimen for women undergoing cesarean delivery resulted in a decrease in opioid use while adequately controlling postoperative pain. A multimodal regimen was associated with early successful exclusive breastfeeding.
仅在美国,每年就有约120万例剖宫产手术。虽然传统的术后疼痛管理策略以前严重依赖阿片类药物,但从业者现在正转向使用多种非麻醉性镇痛药的阿片类药物节省方案。包括妇科在内的其他外科专科已采用多模式疼痛管理系统,不过关于其用于剖宫产术后疼痛管理的数据仍然有限。
确定剖宫产术后多模式疼痛管理方案与传统吗啡患者自控镇痛相比,在充分控制术后疼痛的同时,是否能减少所需的吗啡毫克当量数(阿片类药物的一种计量单位)。
这是一项对一家大型县医院接受剖宫产手术的女性进行术后疼痛管理的前瞻性队列研究。研究在从传统吗啡患者自控镇痛方案过渡到包括定期使用非甾体抗炎药和对乙酰氨基酚、按需使用阿片类药物的多模式方案期间进行。在过渡前后6周内收集数据。主要结局是术后阿片类药物使用情况,定义为前48小时内的吗啡毫克当量。次要结局包括连续疼痛评分、出院时间和纯母乳喂养率。需要全身麻醉或有药物滥用障碍病史的女性被排除在外。统计分析包括学生t检验、Wilcoxon秩和检验以及Hodges-Lehman偏移检验,P值<0.05被认为具有统计学意义。
在研究期间,877名女性接受了剖宫产手术,778名符合纳入标准——378名接受传统吗啡患者自控镇痛,400名接受多模式方案。多模式方案的实施导致前48小时内吗啡毫克当量的使用显著减少(28[14-41]吗啡毫克当量对128[86-174]吗啡毫克当量;P<0.001)。与传统组相比,多模式组中更多女性在48小时时报告疼痛评分≤4(88%对77%;P<0.001)。出院时间没有差异(P=0.32)。在计划纯母乳喂养的女性中,多模式组在出院前使用配方奶的女性少于传统组(9%对12%;P<0.001)。
对于接受剖宫产手术的女性,过渡到多模式疼痛管理方案可减少阿片类药物的使用,同时充分控制术后疼痛。多模式方案与早期成功纯母乳喂养有关。